AIxCrypto Holdings, Inc.
US ˙ NasdaqCM ˙ US74754R2022

簡介

本頁面提供了有關 Matthew E Korenberg 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Matthew E Korenberg已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
Director 69,967
US:LGND / Ligand Pharmaceuticals Incorporated President & COO 50,777
US:QLGN / Qualigen Therapeutics, Inc. Director 50,000
如何解讀這些圖表

以下圖表顯示了在Matthew E Korenberg進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

AIXC / AIxCrypto Holdings, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 AIXC / AIxCrypto Holdings, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AIXC / AIxCrypto Holdings, Inc. Insider Trades
AIXC / AIxCrypto Holdings, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 AIXC / AIxCrypto Holdings, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AIXC / AIxCrypto Holdings, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Matthew E Korenberg 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-06-05 2026-06-04 4 LFCR LIFECORE BIOMEDICAL, INC. \DE\
Common Stock
A - Award 25,907 69,967 58.80
2025-07-17 2025-07-15 4 LFCR LIFECORE BIOMEDICAL, INC. \DE\
Common Stock
A - Award 19,506 44,060 79.44
2024-09-24 2024-09-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -201 50,777 -0.39 102.05 -20,513 5,182,001
2024-09-24 2024-09-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -7,090 50,978 -12.21 101.60 -720,379 5,179,620
2024-09-24 2024-09-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -2,481 58,068 -4.10 100.05 -248,228 5,809,802
2024-09-24 2024-09-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 9,377 60,549 18.32 52.84 495,481 3,199,409
2024-09-24 2024-09-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 395 51,172 0.78 49.99 19,746 2,558,088
2024-09-24 2024-09-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -6,275 50,777 -11.00 104.10 -653,238 5,285,972
2024-09-24 2024-09-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4,982 57,052 9.57 49.99 249,050 2,852,029
2024-09-18 2024-09-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,938 52,070 -3.59 105.00 -203,490 5,467,350
2024-09-18 2024-09-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 3,340 54,008 6.59 60.94 203,540 3,291,248
2024-09-18 2024-09-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -319 50,668 -0.63 105.00 -33,495 5,320,140
2024-09-18 2024-09-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 671 50,987 1.33 49.99 33,543 2,548,840
2024-09-18 2024-09-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -472 50,316 -0.93 105.00 -49,560 5,283,180
2024-09-18 2024-09-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 849 50,788 1.70 58.49 49,658 2,970,590
2024-09-18 2024-09-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -485 49,939 -0.96 105.00 -50,925 5,243,595
2024-09-18 2024-09-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 914 50,424 1.85 55.75 50,956 2,811,138
2024-08-26 2024-08-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5,212 49,510 -9.52 106.32 -554,147 5,263,973
2024-08-26 2024-08-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -6,177 54,722 -10.14 105.02 -648,684 5,746,686
2024-08-26 2024-08-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4,275 60,899 -6.56 105.13 -449,439 6,402,428
2024-08-26 2024-08-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -2,037 65,174 -3.03 104.09 -212,040 6,784,255
2024-08-26 2024-08-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1,157 67,211 -1.69 105.54 -122,110 7,093,449
2024-08-21 3 LFCR LIFECORE BIOMEDICAL, INC. \DE\
No Security beneficially owned
0
2024-08-21 2024-08-19 4 LFCR LIFECORE BIOMEDICAL, INC. \DE\
Common Stock
A - Award 24,554 24,554
2024-08-13 2024-08-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -18,245 68,368 -21.06 98.50 -1,797,132 6,734,248
2024-07-02 2024-06-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 350 86,613 0.41 60.71 21,247 5,258,015
2024-05-15 2024-05-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -520 86,263 -0.60 85.68 -44,556 7,391,368
2024-05-15 2024-05-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -13,638 86,783 -13.58 85.08 -1,160,356 7,383,723
2024-05-15 2024-05-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3,440 100,421 -3.31 84.54 -290,828 8,489,903
2024-02-29 2024-02-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 14,416 103,861 16.12
2024-02-16 2024-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -4,778 89,445 -5.07 74.65 -356,678 6,677,069
2024-01-04 2024-01-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,917 94,223 -3.00 72.31 -210,928 6,813,265
2023-12-06 2023-12-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,984 97,140 -2.00 59.61 -118,266 5,790,515
2023-07-10 2023-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 376 99,124 0.38 56.78 21,349 5,628,261
2023-02-27 2023-02-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9,069 98,748 10.11
2023-02-17 2023-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,890 89,679 -3.12 72.98 -210,912 6,544,773
2022-12-30 2022-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3,859 92,569 -4.00 66.29 -255,813 6,136,399
2022-12-15 2022-12-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 14,000 96,428 16.98
2022-12-01 2022-11-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3,593 82,428 -4.18 72.90 -261,930 6,009,001
2022-11-03 2022-11-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 27,714 86,021 47.53
2022-07-06 2022-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 164 52,532 0.31 75.84 12,437 3,983,869
2022-06-14 2022-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 8,062 52,368 18.20
2022-05-09 2022-05-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 30,189 30,189
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,532 44,306 -3.34 123.68 -189,478 5,479,766
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -969 45,838 -2.07 123.68 -119,846 5,669,244
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -906 46,807 -1.90 123.68 -112,054 5,789,090
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,309 47,713 -4.62 113.68 -262,487 5,424,014
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,319 50,022 -2.57 113.68 -149,944 5,686,501
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6,848 51,341 15.39
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 4,803 44,493 12.10
2021-07-02 2021-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 247 39,690 0.63 85.91 21,220 3,409,748
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -969 39,443 -2.40 172.46 -167,114 6,802,340
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -906 40,412 -2.19 172.46 -156,249 6,969,454
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -434 41,318 -1.04 172.46 -74,848 7,125,702
2021-02-05 2021-02-03 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 11,591 11,591
2021-02-05 2021-02-03 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 10,819 41,752 34.98
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,440 30,933 -4.45 156.01 -224,654 4,825,857
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 4,803 32,373 17.42
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -671 27,570 -2.38 156.01 -104,683 4,301,196
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2,305 28,241 8.89
2020-07-01 2020-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 238 25,936 0.93 89.03 21,189 2,309,056
2020-06-08 2020-06-06 4 QLGN Qualigen Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 50,000 50,000
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -435 15,303 -2.76 120.86 -52,574 1,849,521
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -377 15,738 -2.34 120.86 -45,564 1,902,095
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -354 16,115 -2.15 120.86 -42,784 1,947,659
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 30,750 30,750
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6,848 26,864 34.21
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -979 20,016 -4.66 105.87 -103,647 2,119,094
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2,305 20,995 12.33
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,135 18,690 -5.73 105.87 -120,162 1,978,710
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2,674 19,825 15.59
2019-09-23 2019-09-19 4 LGND LIGAND PHARMACEUTICALS INC
0.75% Convertible Senior Notes due 2023
P - Purchase 989,937.50
2019-09-03 2019-09-03 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 500 17,151 3.00 86.18 43,091 1,478,099
2019-07-02 2019-06-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 182 16,651 1.11 97.03 17,659 1,615,605
2019-02-13 2019-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 29,298 29,298
2019-02-13 2019-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6,404 16,469 63.63
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -612 10,065 -5.73 111.78 -68,409 1,125,066
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2,230 10,677 26.40
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -713 8,447 -7.78 111.78 -79,699 944,206
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2,418 9,160 35.86
2018-08-29 2018-08-29 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -11,540 6,924 -62.50
2018-08-29 2018-08-29 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -18,357 6,742 -73.14 256.69 -4,712,060 1,730,605
2018-08-29 2018-08-29 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 11,540 25,099 85.11 85.79 990,017 2,153,243
2018-08-07 2018-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -836 13,559 -5.81 226.74 -189,555 3,074,368
2018-07-03 2018-06-29 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 180 14,395 1.27 117.84 21,210 1,696,242
2018-03-06 2018-03-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -550 14,215 -3.73 165.87 -91,228 2,357,842
2018-03-06 2018-03-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2,004 14,765 15.70
2018-03-06 2018-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 16,050 16,050
2018-03-06 2018-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3,074 12,761 31.73
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -326 9,687 -3.26 157.18 -51,241 1,522,603
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -354 10,013 -3.41 157.18 -55,642 1,573,843
2017-12-29 2017-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,530 10,367 -12.86 138.66 -212,150 1,437,488
2017-12-29 2017-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3,750 11,897 46.03
2017-11-17 2017-11-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -6,559 8,147 -44.60 142.63 -935,510 1,162,007
2017-08-08 2017-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -609 14,706 -3.98 122.06 -74,335 1,795,014
2017-07-05 2017-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 243 15,315 1.61 87.12 21,171 1,334,319
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 15,225 15,225
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3,567 15,072 31.00
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,051 11,505 -8.37 100.38 -105,499 1,154,872
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3,450 12,556 37.89
2017-02-28 2017-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -391 9,106 -4.12 104.28 -40,773 949,574
2017-02-28 2016-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -609 9,457 -6.05 123.30 -75,090 1,166,048
2017-01-03 2016-12-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 40 10,106 0.40 86.37 3,455 872,840
2016-07-05 2016-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 196 10,066 1.99 87.10 17,072 876,744
2016-02-16 2016-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 18,464 18,464
2016-02-16 2016-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3,870 9,870 64.50
2015-08-07 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 25,000 25,000
2015-08-07 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6,000 6,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)